MLTX vs. ^GSPC
Compare and contrast key facts about MoonLake Immunotherapeutics (MLTX) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MLTX or ^GSPC.
Correlation
The correlation between MLTX and ^GSPC is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MLTX vs. ^GSPC - Performance Comparison
Key characteristics
MLTX:
-0.24
^GSPC:
0.24
MLTX:
-0.02
^GSPC:
0.47
MLTX:
1.00
^GSPC:
1.07
MLTX:
-0.24
^GSPC:
0.24
MLTX:
-0.73
^GSPC:
1.08
MLTX:
16.23%
^GSPC:
4.25%
MLTX:
49.26%
^GSPC:
19.00%
MLTX:
-64.60%
^GSPC:
-56.78%
MLTX:
-39.99%
^GSPC:
-14.02%
Returns By Period
In the year-to-date period, MLTX achieves a -29.22% return, which is significantly lower than ^GSPC's -10.18% return.
MLTX
-29.22%
-4.00%
-21.69%
-9.29%
N/A
N/A
^GSPC
-10.18%
-6.92%
-9.92%
5.42%
12.98%
9.70%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MLTX vs. ^GSPC — Risk-Adjusted Performance Rank
MLTX
^GSPC
MLTX vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
MLTX vs. ^GSPC - Drawdown Comparison
The maximum MLTX drawdown since its inception was -64.60%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for MLTX and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
MLTX vs. ^GSPC - Volatility Comparison
MoonLake Immunotherapeutics (MLTX) has a higher volatility of 19.10% compared to S&P 500 (^GSPC) at 13.60%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.